Screener
Syndax Pharmaceuticals SNDX Free cash flow
Discontinued — last reported Q4 '25
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Syndax Pharmaceuticals’s reported figures.
The source filing: Syndax Pharmaceuticals’s 10-K, filed February 26, 2026. Open the filing →
- Filed
- Feb 26, 2026, 4:04 PM EST
- Fiscal year
- FY2025
- Accession
- 0001193125-26-076536
FAQ
- What is Syndax Pharmaceuticals's free cash flow?
- Syndax Pharmaceuticals (SNDX) reported free cash flow of -$80.79M in Q4 2025.
- How has Syndax Pharmaceuticals's free cash flow changed year-over-year?
- Syndax Pharmaceuticals's free cash flow decreased by 17.6% year-over-year, from -$68.73M to -$80.79M.
- What is the long-term trend for Syndax Pharmaceuticals's free cash flow?
- Over 4 years (2021 to 2025), Syndax Pharmaceuticals's free cash flow has grown at a 82.7% compound annual growth rate (CAGR), from $29M to -$323.17M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Syndax Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude